IHI - iShares US Medical Devices ETF
| Previous Close | 220.39 |
| Open | 221.83 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 900 |
| Day's Range | 221.72 - 223.89 |
| 52 Week Range | 178.75 - 228.90 |
| Volume | 188,867 |
| Avg. Volume | 223,098 |
| Net Assets | 2.78B |
| NAV | 223.78 |
| PE Ratio (TTM) | N/A |
| Yield | 0.25% |
| YTD Return | 12.02% |
| Beta (3Y Monthly) | 1.08 |
| Expense Ratio (net) | 0.43% |
| Inception Date | 2006-05-01 |
- Market Realist•16 days ago
Analysts Are Optimistic ahead of Boston Scientific’s Q4 Results
Analysts Are Optimistic ahead of Boston Scientific's Q4 ResultsAnalysts’ recommendations and target priceBoston Scientific (BSX) is scheduled to post its fourth-quarter and 2018 earnings results on February 6, 2019. In this article, we’ll
- ETF Trends•24 days ago
Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook
Healthcare ETFs weakened Wednesday after Abbot Laboratories (ABT) slipped on a revenue miss and revealed an uninspiring forecast for the first quarter of the new year. The Health Care Select Sector SPDR ETF (XLV) fell 0.3% on Wednesday while the S&P 500 was 0.1% lower. Abbot Laboratories' quarterly revenue fell short of expectations due to lower sales of generic drugs in the emerging markets, Reuters reports.
- Investopedia•last month
Top Performing Health Care ETFs of 2018
The health care sector spent much of 2018 as the strongest performer across the market. For investors looking to take part in the health care sector, one of the easiest and most popular options is an exchange-traded fund (ETF). Given the popularity of the health care sector ETF space and the relative success of this corner of the financial world, there were several health care ETFs which were among the top performing ETFs overall for 2018.
Market Realist•last monthWhat’s Driving TransEnterix Stock on January 8?
On January 8, TransEnterix (TRXC) rose 11.15% compared to its previous closing price and reached $2.99 in its pre-market trading session. On January 7, TransEnterix issued a press release announcing its preliminary operational and financial performance for the fourth quarter and fiscal 2018. Based on the closing price on January 7, TransEnterix reported returns of 9.80% in the last week, -13.50% in the last month, and -53.70% in the last quarter.
- Zacks•last month
Best Sector of 2018 and its Hit ETFs & Stocks
Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.
- Zacks•last month
10 Top-Ranked ETFs That Crushed the Market in 2018
While there have been losers in most corner of the space, several ETFs still managed to end the year in green and are likely to continue outperforming in 2019 too.
- Investor's Business Daily•2 months ago
These 3 Top Sector Plays Are Still Trouncing The Stock Market
What market sell-off? These three sector ETFs wrapped up 2018 with double-digit gains even though Wall Street stumbled in October and fell hard.
- Zacks•2 months ago
4 Sector ETFs Surviving the Market Rout in 2018
While most of the sectors are in red this year, a few ETFs are easily surviving the market rout.
- Zacks•2 months ago
A Look at the Christmas Tree of Top-Ranked ETFs
We have built a tree with the top-ranked ETFs that have the potential to outperform in 2019.
Investor's Business Daily•2 months ago3 Best ETF Ideas For Investors Include Dividend, China FANG Plays
Beaumont Capital Management aims to make investors comfortable by helping capture upside gains and protect against steep potential losses.
Market Realist•2 months agoA Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019
Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018. Medtronic’s net income in the first half of fiscal 2019 totaled $2.2 billion compared to $3.0 billion in the same period the prior year. Wall Street analysts anticipate that Medtronic is expected to report net income of $1.25 billion in the third quarter of fiscal 2019.
Market Realist•2 months agoHow Does Medtronic’s Restorative Therapies & Diabetes Group Look?
Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty, and Pain therapies. Medtronic’s Restorative Therapies Group generated revenues of $2.0 billion in the second quarter of fiscal 2019 compared to $1.9 billion in the second quarter of fiscal 2018, reflecting ~7% YoY growth.
Zacks•2 months agoTop Sector ETFs of 2018
These sector ETFs exceled in 2018 despite a few severe broader market crashes.
- ETF Trends•3 months ago
ETFs to Help Investors Pick and Choose Their Market Exposures
Markets have often rallied in the months after midterm elections (see chart below), but we are focused on what the new government makeup could mean for these sectors," Christopher Dhanraj, Director and Head of iShares Investment Strategy, said in a research note. Specifically, Dhanraj highlighted three U.S. segments to closely watch ahead. Something like the iShares U.S. Aerospace & Defense ETF (ITA) can be a pure play for those seeking exposure to the defense sector.
Market Realist•3 months agoWall Street Analysts Are Mostly Positive on Abiomed
On November 26, Abiomed (ABMD) stock closed at $311.15, a ~3.92% rise from its previous day’s close of $299.41 on November 23. Abiomed stock rose from $187.41 at the close of market on December 29, 2017, to $311.15 at the close of market on November 26, 2018, reflecting a ~66% year-to-date rise.
Market Realist•3 months agoWhy Analysts Are Mostly Positive on Boston Scientific Stock
Boston Scientific (BSX) stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23, 2018, reflecting a rise of ~40% year-to-date. On November 23, Boston Scientific stock closed at $34.80, a ~42% rise from its 52-week low of $24.54 on December 6, 2017.
Market Realist•3 months agoIntuitive Surgical Stock Has Seen Growth of 34% Year-to-Date
Intuitive Surgical’s (ISRG) stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018, reflecting a ~34% year-to-date rise.
Market Realist•3 months agoInside General Electric’s Healthcare Business Unit Spin-Off Plan
As part of its major restructuring plan, General Electric (GE) intends to spin off its Healthcare segment and turn it into a standalone entity. The company has planned the spin-off in a manner that maximizes shareholder wealth.
- ETF Trends•3 months ago
Leveraged Healthcare ETF Gains On Midterm Election Results
Even as the Democrats retook control of the House of Representatives and the Republicans maintained majority in the Senate, healthcare ETFs were also big winners following the 2018 Midterm Election results. ...
- ETF Trends•3 months ago
Healthcare ETFs in Focus Ahead of Election Day
Count the iShares US Medical Devices ETF (NYSEArca: IHI) and the iShares US Healthcare ETF (NYSEArca: IYH) among the healthcare exchange traded funds that could be affected by the results of the upcoming ...
- Market Realist•4 months ago
Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings
Thermo Fisher Scientific (TMO) reported its third quarter of 2018 results today, October 24. It surpassed Wall Street analysts’ estimates for both EPS and revenue. Its non-GAAP EPS was $2.62, and its revenues were $5.92 billion. That compares to analysts’ EPS estimate of $2.55 on revenues of $5.7 billion.
- Market Realist•4 months ago
Thermo Fisher’s Third-Quarter Revenue Estimates
As we discussed in the previous part, Wall Street analysts expect Thermo Fisher Scientific (TMO) to report 11.5% revenue growth to $5.70 billion during the third quarter. Thermo Fisher provides products and services through its brands including Thermo Scientific, Fisher Scientific, Invitrogen, Unity Lab Services, and Applied Biosystems.
Market Realist•4 months agoZimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings
Zimmer Biomet Holdings (ZBH) plans to release its third-quarter earnings on October 26. Wall Street analysts expect ZBH to generate revenues of $1.8 billion in the third quarter.
Market Realist•4 months agoWhat to Expect from Medtronic’s Diabetes Segment
In September 2018, Medtronic (MDT) announced that the company would acquire all outstanding shares of Mazor Robotics (MZOR) for $58.50 per American depositary share (or $29.25 per ordinary share), which amounts to a total of $1.64 billion (or $1.34 billion). Both companies’ boards of directors unanimously approved the transaction.
- ETF Trends•4 months ago
Health Care ETFs Retreat on DOJ Approval of Aetna-CVS Merger
The Department of Justice issued a preliminary approval for CVS Pharmacy to acquire health care insurance company Aetna, possibly paving the way for transformative changes in the industry as cries for more affordable care emanating from consumers and regulators get louder. The Health Care Select Sector SPDR ETF (XLV) slid 0.42% as of 11:45 a.m. ET, Vanguard Health Care ETF (VHT) fell 0.54%, iShares US Medical Devices ETF (IHI) was down 1.21%, and iShares US Healthcare ETF (IYH) slid 0.55%. As part of the approval process, the DOJ set forth the condition that Aetna had to divest itself from its Medicare Part D drug plan, which it eventually sold to WellCare Health Plans for an undisclosed amount late last month.
